274 related articles for article (PubMed ID: 32170926)
1. Macrophage lineages in heart valve development and disease.
Kim AJ; Xu N; Yutzey KE
Cardiovasc Res; 2021 Feb; 117(3):663-673. PubMed ID: 32170926
[TBL] [Abstract][Full Text] [Related]
2. Macrophage Transitions in Heart Valve Development and Myxomatous Valve Disease.
Hulin A; Anstine LJ; Kim AJ; Potter SJ; DeFalco T; Lincoln J; Yutzey KE
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):636-644. PubMed ID: 29348122
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
Kim AJ; Xu N; Umeyama K; Hulin A; Ponny SR; Vagnozzi RJ; Green EA; Hanson P; McManus BM; Nagashima H; Yutzey KE
Circulation; 2020 Jan; 141(2):132-146. PubMed ID: 31928435
[TBL] [Abstract][Full Text] [Related]
4. Twist1 promotes heart valve cell proliferation and extracellular matrix gene expression during development in vivo and is expressed in human diseased aortic valves.
Chakraborty S; Wirrig EE; Hinton RB; Merrill WH; Spicer DB; Yutzey KE
Dev Biol; 2010 Nov; 347(1):167-79. PubMed ID: 20804746
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of heart valve development and disease.
O'Donnell A; Yutzey KE
Development; 2020 Jul; 147(13):. PubMed ID: 32620577
[TBL] [Abstract][Full Text] [Related]
6. Endothelial Cell Lineage Analysis Does Not Provide Evidence for EMT in Adult Valve Homeostasis and Disease.
Kim AJ; Alfieri CM; Yutzey KE
Anat Rec (Hoboken); 2019 Jan; 302(1):125-135. PubMed ID: 30306735
[TBL] [Abstract][Full Text] [Related]
7. Morphology, Clinicopathologic Correlations, and Mechanisms in Heart Valve Health and Disease.
Schoen FJ
Cardiovasc Eng Technol; 2018 Jun; 9(2):126-140. PubMed ID: 27502286
[TBL] [Abstract][Full Text] [Related]
8. Heart valve development: regulatory networks in development and disease.
Combs MD; Yutzey KE
Circ Res; 2009 Aug; 105(5):408-21. PubMed ID: 19713546
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Special Issue on Heart Valve Mechanobiology : New Insights into Mechanical Regulation of Valve Disease and Regeneration.
Simmons CA; Jo H
Cardiovasc Eng Technol; 2018 Jun; 9(2):121-125. PubMed ID: 29761407
[No Abstract] [Full Text] [Related]
10. PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves.
Ho YC; Geng X; O'Donnell A; Ibarrola J; Fernandez-Celis A; Varshney R; Subramani K; Azartash-Namin ZJ; Kim J; Silasi R; Wylie-Sears J; Alvandi Z; Chen L; Cha B; Chen H; Xia L; Zhou B; Lupu F; Burkhart HM; Aikawa E; Olson LE; Ahamed J; López-Andrés N; Bischoff J; Yutzey KE; Srinivasan RS
Circ Res; 2023 Sep; 133(6):463-480. PubMed ID: 37555328
[TBL] [Abstract][Full Text] [Related]
11. RNA-seq analysis to identify novel roles of scleraxis during embryonic mouse heart valve remodeling.
Barnette DN; VandeKopple M; Wu Y; Willoughby DA; Lincoln J
PLoS One; 2014; 9(7):e101425. PubMed ID: 24983472
[TBL] [Abstract][Full Text] [Related]
12. Degenerating heart valves: fill them up with filamin?
Charitakis K; Basson CT
Circulation; 2007 Jan; 115(1):2-4. PubMed ID: 17200451
[No Abstract] [Full Text] [Related]
13. Primary myxomatous degeneration of cardiac valves. Clinical, pathological, haemodynamic, and echocardiographic profile.
Rippe J; Fishbein MC; Carabello B; Angoff G; Sloss L; Collins JJ; Alpert JS
Br Heart J; 1980 Dec; 44(6):621-9. PubMed ID: 7459145
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol induced heart valve inflammation and injury: efficacy of cholesterol lowering treatment.
El-Khatib LA; De Feijter-Rupp H; Janoudi A; Fry L; Kehdi M; Abela GS
Open Heart; 2020 Aug; 7(2):. PubMed ID: 32747455
[TBL] [Abstract][Full Text] [Related]
15. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
Hulin A; Moore V; James JM; Yutzey KE
Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
[TBL] [Abstract][Full Text] [Related]
16. Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves.
Barnette DN; Hulin A; Ahmed AS; Colige AC; Azhar M; Lincoln J
J Mol Cell Cardiol; 2013 Dec; 65():137-46. PubMed ID: 24157418
[TBL] [Abstract][Full Text] [Related]
17. Role of angiogenetic factors in cardiac valve homeostasis and disease.
Hakuno D; Kimura N; Yoshioka M; Fukuda K
J Cardiovasc Transl Res; 2011 Dec; 4(6):727-40. PubMed ID: 21866383
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of human heart valves: does anorexigen exposure produce a distinctive morphological lesion?
McDonald PC; Wilson JE; Gao M; McNeill S; Spinelli JJ; Williams OD; Harji S; Kenyon J; McManus BM
Cardiovasc Pathol; 2002; 11(5):251-62. PubMed ID: 12361835
[TBL] [Abstract][Full Text] [Related]
19. Role of inflammation in nonrheumatic, regurgitant heart valve disease. A comparative, descriptive study regarding apolipoproteins and inflammatory cells in nonrheumatic heart valve disease.
Wallby L; Steffensen T; Broqvist M
Cardiovasc Pathol; 2007; 16(3):171-8. PubMed ID: 17502247
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamics driven cardiac valve morphogenesis.
Steed E; Boselli F; Vermot J
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1760-6. PubMed ID: 26608609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
